MYO7A p.Ala1540Val
c.4619C>T · rs111033511 · VCV43250
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0816 | likely benign |
|---|---|---|
| REVEL | 0.101 | moderately benign-leaning |
| SaProt | LLR -6.38 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | Δ0.27 | acceptor gain · deltas |
| Constraint at this position | ||
| Conservation | phyloP 1.4 | GERP -2.2, phastCons 0.034 |
| Regional constraint | o/e 0.95 | unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic |
| Overall | ||
| CADD | 17.64 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.31% | 323 |
| Middle Eastern | 0.0515% | 1,941 |
| Remaining individualsnot grpmax-eligible | 0.0213% | 4,684 |
| European (non-Finnish) | 0.00803% | 12,446 |
| African / African-American | 0.00404% | 24,743 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00351% | 28,466 |
| Admixed American | 0.00182% | 54,810 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MYO7A
- Protein
- p.Ala1540Val
- Coding
- c.4619C>T
- MANE Select
- NM_000260
- dbSNP
- rs111033511
- Type
- single nucleotide variant
- Location
- chr11:77199585 (GRCh38)
- Gene constraint
- LOEUF 0.995 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 77.73 · 1 PDB
- Residue 1540
- the ferm 1 domain
Disease context
Usher syndrome type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: autosomal recessive nonsyndromic hearing loss 2autosomal dominant nonsyndromic hearing loss 11
For Usher syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Worldwide)
Similar variants
- MYO7A p.Ala1540= Conflicting classifications of pathogenicity ★ same residue
- MYO7A p.Ala1540Glu Uncertain significance ★ ⚠ same residue
- MYO7A p.Ala1288Pro Likely pathogenic ★★★ same condition
- MYO7A p.Arg1168Gln Pathogenic ★★★ ⚠ same condition
- MYO7A p.Arg1873Gln Pathogenic ★★★ ⚠ same condition
- MYO7A p.Arg395Cys Likely pathogenic ★★★ ⚠ same condition
- MYO7A p.Arg668Cys Pathogenic ★★★ same condition
- MYO7A p.Arg853His Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-ala1540val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown